These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 23707971

  • 1. Tandospirone suppresses impulsive action by possible blockade of the 5-HT1A receptor.
    Ohmura Y, Kumamoto H, Tsutsui-Kimura I, Minami M, Izumi T, Yoshida T, Yoshioka M.
    J Pharmacol Sci; 2013; 122(2):84-92. PubMed ID: 23707971
    [Abstract] [Full Text] [Related]

  • 2. Effect of tandospirone, a serotonin-1A receptor partial agonist, on information processing and locomotion in dizocilpine-treated rats.
    Bubenikova-Valesova V, Svoboda J, Horacek J, Sumiyoshi T.
    Psychopharmacology (Berl); 2010 Oct; 212(2):267-76. PubMed ID: 20676611
    [Abstract] [Full Text] [Related]

  • 3. Prolonged reversal of the phencyclidine-induced impairment in novel object recognition by a serotonin (5-HT)1A-dependent mechanism.
    Horiguchi M, Miyauchi M, Neugebauer NM, Oyamada Y, Meltzer HY.
    Behav Brain Res; 2016 Mar 15; 301():132-41. PubMed ID: 26342283
    [Abstract] [Full Text] [Related]

  • 4. Chronic treatment with tandospirone, a serotonin 1A receptor partial agonist, inhibits psychosocial stress-induced changes in hippocampal neurogenesis and behavior.
    Murata Y, Yanagihara Y, Mori M, Mine K, Enjoji M.
    J Affect Disord; 2015 Jul 15; 180():1-9. PubMed ID: 25879718
    [Abstract] [Full Text] [Related]

  • 5. Chronic treatment with tandospirone, a 5-HT(1A) receptor partial agonist, suppresses footshock stress-induced lactate production in the prefrontal cortex of rats.
    Uehara T, Matsuoka T, Itoh H, Sumiyoshi T.
    Pharmacol Biochem Behav; 2013 Nov 15; 113():1-6. PubMed ID: 24125783
    [Abstract] [Full Text] [Related]

  • 6. Effects of tandospirone, a 5-HT1A agonistic anxiolytic agent, on haloperidol-induced catalepsy and forebrain Fos expression in mice.
    Ohno Y, Shimizu S, Imaki J.
    J Pharmacol Sci; 2009 Apr 15; 109(4):593-9. PubMed ID: 19352073
    [Abstract] [Full Text] [Related]

  • 7. Effects of the 5-HT(1A) Receptor Agonist Tandospirone on ACTH-Induced Sleep Disturbance in Rats.
    Tsutsui R, Shinomiya K, Sendo T, Kitamura Y, Kamei C.
    Biol Pharm Bull; 2015 Apr 15; 38(6):884-8. PubMed ID: 26027828
    [Abstract] [Full Text] [Related]

  • 8. Tandospirone, a 5-HT1A agonist, ameliorates movement disorder via non-dopaminergic systems in rats with unilateral 6-hydroxydopamine-generated lesions.
    Matsubara K, Shimizu K, Suno M, Ogawa K, Awaya T, Yamada T, Noda T, Satomi M, Ohtaki K, Chiba K, Tasaki Y, Shiono H.
    Brain Res; 2006 Sep 27; 1112(1):126-33. PubMed ID: 16884702
    [Abstract] [Full Text] [Related]

  • 9. [Anti-impulsivity drugs and their mechanisms of action].
    Ohmura Y, Tsutsui-Kimura I, Yoshioka M.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2014 Apr 27; 34(2):41-8. PubMed ID: 25080806
    [Abstract] [Full Text] [Related]

  • 10. Tandospirone activates neuroendocrine and ERK (MAP kinase) signaling pathways specifically through 5-HT1A receptor mechanisms in vivo.
    Sullivan NR, Crane JW, Damjanoska KJ, Carrasco GA, D'Souza DN, Garcia F, Van de Kar LD.
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan 27; 371(1):18-26. PubMed ID: 15655673
    [Abstract] [Full Text] [Related]

  • 11. The effects of AP521, a novel anxiolytic drug, in three anxiety models and on serotonergic neural transmission in rats.
    Kasahara K, Hashimoto S, Hattori T, Kawasaki K, Tsujita R, Nakazono O, Takao K, Kawakubo H, Nagatani T.
    J Pharmacol Sci; 2015 Jan 27; 127(1):109-16. PubMed ID: 25704026
    [Abstract] [Full Text] [Related]

  • 12. The serotonin 5-HT₁A receptor agonist tandospirone improves executive function in common marmosets.
    Baba S, Murai T, Nakako T, Enomoto T, Ono M, Shimizu I, Ikeda K.
    Behav Brain Res; 2015 Jan 27; 287():120-6. PubMed ID: 25804359
    [Abstract] [Full Text] [Related]

  • 13. Presynaptic modulation of synaptic gamma-aminobutyric acid transmission by tandospirone in rat basolateral amygdala.
    Kishimoto K, Koyama S, Akaike N.
    Eur J Pharmacol; 2000 Nov 03; 407(3):257-65. PubMed ID: 11068021
    [Abstract] [Full Text] [Related]

  • 14. 5-HT1A receptor agonists induce anterograde amnesia in mice through a postsynaptic mechanism.
    Mendelson SD, Quartermain D, Francisco T, Shemer A.
    Eur J Pharmacol; 1993 May 19; 236(2):177-82. PubMed ID: 8319749
    [Abstract] [Full Text] [Related]

  • 15. Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine--I. Effects of acute and long-term administration of tandospirone on serotonin neurotransmission.
    Godbout R, Chaput Y, Blier P, de Montigny C.
    Neuropharmacology; 1991 Jul 19; 30(7):679-90. PubMed ID: 1681446
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effects of tandospirone, a 5-HT1A agonist, on medial vestibular nucleus neurons responding to lateral roll tilt stimulation in rats.
    Amano T, Akbar M, Matsubayashi H, Sasa M.
    Brain Res; 2001 Aug 10; 910(1-2):195-8. PubMed ID: 11489272
    [Abstract] [Full Text] [Related]

  • 17. Effects of tandospirone on second messenger systems and neurotransmitter release in the rat brain.
    Tanaka H, Tatsuno T, Shimizu H, Hirose A, Kumasaka Y, Nakamura M.
    Gen Pharmacol; 1995 Dec 10; 26(8):1765-72. PubMed ID: 8745167
    [Abstract] [Full Text] [Related]

  • 18. Successful treatment of blepharospasm with tandospirone, a 5-HT1A partial agonist: a case report.
    Takahashi T, Murata T, Wada Y.
    Mov Disord; 2008 Jan 10; 23(1):151-2. PubMed ID: 17987656
    [No Abstract] [Full Text] [Related]

  • 19. [A new approach to innovating selective anxiolytics: pharmacological profile of a novel 5-HT1A agonist (tandospirone)].
    Sasa M.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Apr 10; 17(2):53-9. PubMed ID: 9201724
    [Abstract] [Full Text] [Related]

  • 20. In vivo drug action of tandospirone at 5-HT1A receptor examined using positron emission tomography and neuroendocrine response.
    Nakayama T, Suhara T, Okubo Y, Ichimiya T, Yasuno F, Maeda J, Takano A, Saijo T, Suzuki K.
    Psychopharmacology (Berl); 2002 Dec 10; 165(1):37-42. PubMed ID: 12474116
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.